Mark Eisner, EVP and Chief Medical Officer: Vir Biotechnology VIR Sell · Filed 02/24

Trade details

Type: Insider sale
Amount: $15,563.05
Shares · price: 2,089 sh · $7.45 a share
Held after: 157,529 sh
Stock: Vir Biotechnology VIR
Person: Mark EisnerEVP and Chief Medical Officer
Trade date: 26/02/23
Filed: 26/02/24
Days to filing: 1 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Vir Biotechnology trades, last 26 weeks

What else happened in Vir Biotechnology around then

Filed or reported within 30 days of the trade day · 01/24~03/25

Mark Eisner's recent trades

Mark EisnerFormer Officer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$916.3K
88,958 sh
$916.3K
Filed 04/30
Traded 04/30
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/26
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.4K
1,616 sh
$15.4K
Filed 02/26
Traded 02/24
Mark EisnerOfficer
Planned sale10b5-1 planVir Biotechnology
Planned sale10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/25
Traded 02/25
Mark EisnerOfficer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$15.4K
1,616 sh
$15.4K
Filed 02/24
Traded 02/24